title: Botryomycosis in a child with acquired immunodeficiency syndrome.
authors.affiliation: Division of Infectious Diseases, Childrens' Memorial Hospital and Northwestern University Medical School, Chicago, IL, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Gavin
authors.forename: L
authors.initials: L
authors.lastname: Das
authors.forename: E G
authors.initials: EG
authors.lastname: Chadwick
authors.forename: R
authors.initials: R
authors.lastname: Yogev
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000904:Antibiotics, Antitubercular / Q000008:administration & dosage / Q000627:therapeutic use; D002506:Cephalexin / Q000008:administration & dosage / Q000627:therapeutic use; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008198:Lymph Nodes / Q000382:microbiology / Q000473:pathology; D010336:Pathology; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D013211:Staphylococcus aureus / Q000302:isolation & purification / Q000472:pathogenicity; D016896:Treatment Outcome
chemical_list: D000904:Antibiotics, Antitubercular; D002511:Cephalosporins; D002506:Cephalexin; D012293:Rifampin